Found: 67
Select item for more details and to access through your institution.
Incorporating radiation with anti‐CD19 chimeric antigen receptor T‐cell therapy for relapsed/refractory non‐Hodgkin lymphoma: A multicenter consensus approach.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 1, p. 124, doi. 10.1002/ajh.27155
- By:
- Publication type:
- Article
362 A Novel Animal Model of Radiation-Induced Heart Disease Using Photon Radiation.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Assessment of Lymphoma and Other Hematologic Malignancies Training Needs Among Radiation Oncology Residents: a Brief Report.
- Published in:
- Journal of Cancer Education, 2023, v. 38, n. 1, p. 201, doi. 10.1007/s13187-021-02098-9
- By:
- Publication type:
- Article
Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade Lymphomas.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 4, p. 259, doi. 10.1016/j.clml.2023.01.010
- By:
- Publication type:
- Article
Real World Long-term Follow-up Experience with Yttrium-90 ibritumomab tiuxetan in Previously Untreated Patients with Low-Grade Follicular Lymphoma and Marginal Zone Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. 618, doi. 10.1016/j.clml.2022.03.004
- By:
- Publication type:
- Article
Outcomes of Hepatosplenic T-Cell Lymphoma: The Mayo Clinic Experience.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Carbon ion radiation therapy in breast cancer: a new frontier.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 2, p. 291, doi. 10.1007/s10549-020-05641-2
- By:
- Publication type:
- Article
Outcomes of patients with stage I–II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapy.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 8, p. 1, doi. 10.1038/s41408-022-00711-8
- By:
- Publication type:
- Article
Consolidative Proton Therapy Following High-dose Chemotherapy and Autologous Stem Cell Transplant in an Adolescent with Relapsed Hodgkin Lymphoma.
- Published in:
- Journal of Adolescent & Young Adult Oncology, 2011, v. 1, n. 2, p. 103
- By:
- Publication type:
- Article
Very low-dose radiation therapy for management of inflammatory myofibroblastic tumor of the lung.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Very low-dose radiation therapy for management of inflammatory myofibroblastic tumor of the lung.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Optimal Therapy for Early-Stage Hodgkin's Lymphoma: Risk Adapting, Response Adapting, and Role of Radiotherapy.
- Published in:
- Current Oncology Reports, 2017, v. 19, n. 5, p. 1, doi. 10.1007/s11912-017-0592-7
- By:
- Publication type:
- Article
Impact of Detecting Occult Pathologic Nodal Disease During Resection for Malignant Pleural Mesothelioma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Five- and seven-year outcomes for image-guided moderately accelerated hypofractionated proton therapy for prostate cancer.
- Published in:
- Acta Oncologica, 2022, v. 61, n. 4, p. 468, doi. 10.1080/0284186X.2021.2016948
- By:
- Publication type:
- Article
Image-guided hypofractionated double-scattering proton therapy in the management of centrally-located early-stage non-small cell lung cancer.
- Published in:
- Acta Oncologica, 2020, v. 59, n. 10, p. 1164, doi. 10.1080/0284186X.2020.1759821
- By:
- Publication type:
- Article
Tomayto, tomahto: prescription dose and mean heart dose in evaluating the cardiac impact of involved-field radiation therapy for Hodgkin lymphoma survivors.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registries.
- Published in:
- Acta Oncologica, 2019, v. 58, n. 7, p. 1036, doi. 10.1080/0284186X.2019.1575981
- By:
- Publication type:
- Article
Impact of unfavorable factors on outcomes among inoperable stage II-IV Nonsmall cell lung cancer patients treated with proton therapy.
- Published in:
- Acta Oncologica, 2019, v. 58, n. 3, p. 313, doi. 10.1080/0284186X.2018.1546060
- By:
- Publication type:
- Article
Proton therapy in stage II-IV non-small cell lung cancer: pattern of care and impact on trial accrual.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Long-term outcomes following proton therapy for prostate cancer in young men with a focus on sexual health.
- Published in:
- Acta Oncologica, 2018, v. 57, n. 5, p. 582, doi. 10.1080/0284186X.2018.1427886
- By:
- Publication type:
- Article
Five-year outcomes from a prospective trial of image-guided accelerated hypofractionated proton therapy for prostate cancer.
- Published in:
- Acta Oncologica, 2017, v. 56, n. 7, p. 963, doi. 10.1080/0284186X.2017.1287946
- By:
- Publication type:
- Article
Sperm preservation and neutron contamination following proton therapy for prostate cancer study.
- Published in:
- Acta Oncologica, 2017, v. 56, n. 1, p. 17, doi. 10.1080/0284186X.2016.1205219
- By:
- Publication type:
- Article
Proton therapy patterns-of-care and early outcomes for Hodgkin lymphoma: results from the Proton Collaborative Group Registry.
- Published in:
- Acta Oncologica, 2016, v. 55, n. 11, p. 1378, doi. 10.1080/0284186X.2016.1197422
- By:
- Publication type:
- Article
Outcomes in men with large prostates (≥ 60 cm<sup>3</sup>) treated with definitive proton therapy for prostate cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer.
- Published in:
- Acta Oncologica, 2013, v. 52, n. 3, p. 506, doi. 10.3109/0284186X.2013.769063
- By:
- Publication type:
- Article
Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression.
- Published in:
- Acta Oncologica, 2013, v. 52, n. 3, p. 492, doi. 10.3109/0284186X.2013.767983
- By:
- Publication type:
- Article
Hip fractures and pain following proton therapy for management of prostate cancer.
- Published in:
- Acta Oncologica, 2013, v. 52, n. 3, p. 486, doi. 10.3109/0284186X.2012.762995
- By:
- Publication type:
- Article
Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity.
- Published in:
- Acta Oncologica, 2013, v. 52, n. 3, p. 498, doi. 10.3109/0284186X.2012.762997
- By:
- Publication type:
- Article
Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: Results of two prospective trials.
- Published in:
- Acta Oncologica, 2013, v. 52, n. 3, p. 463, doi. 10.3109/0284186X.2013.764467
- By:
- Publication type:
- Article
Proton therapy in a pediatric patient with stage III Hodgkin lymphoma.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Outcomes in men with large prostates (≥ 60 cm<sup>3</sup>) treated with definitive proton therapy for prostate cancer.
- Published in:
- Acta Oncologica, 2013, v. 52, n. 3, p. 470, doi. 10.3109/0284186X.2012.744467
- By:
- Publication type:
- Article
Proton therapy for Hodgkin lymphoma.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 3, p. 203, doi. 10.1007/s11899-014-0212-7
- By:
- Publication type:
- Article
Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: A Children's Oncology Group study.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 6, p. 1192, doi. 10.1111/bjh.18734
- By:
- Publication type:
- Article
Children's Oncology Group's 2023 blueprint for research: Radiation oncology.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, p. 1, doi. 10.1002/pbc.30593
- By:
- Publication type:
- Article
Children's Oncology Group's 2023 blueprint for research: Hodgkin lymphoma.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, p. 1, doi. 10.1002/pbc.30580
- By:
- Publication type:
- Article
Children's Oncology Group's 2023 blueprint for research: Radiation oncology.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, p. 1, doi. 10.1002/pbc.30593
- By:
- Publication type:
- Article
Children's Oncology Group's 2023 blueprint for research: Hodgkin lymphoma.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, p. 1, doi. 10.1002/pbc.30580
- By:
- Publication type:
- Article
Prognostic value of chest x‐ray‐ and CT‐defined large mediastinal adenopathy in high‐risk pediatric Hodgkin lymphoma: A report from the Children's Oncology Group Study AHOD0831.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 8, p. 1, doi. 10.1002/pbc.30452
- By:
- Publication type:
- Article
Pulmonary dose tolerance in hemithorax radiotherapy for Ewing sarcoma of the chest wall: Are we overestimating the risk of radiation pneumonitis?
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 11, p. 1, doi. 10.1002/pbc.29287
- By:
- Publication type:
- Article
Prognostic value of baseline metabolic tumor volume in children and adolescents with intermediate-risk Hodgkin lymphoma treated with chemo-radiation therapy: FDG-PET parameter analysis in a subgroup from COG AHOD0031.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Second tumor risk in children treated with proton therapy.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 7, p. 1, doi. 10.1002/pbc.28941
- By:
- Publication type:
- Article
Expert consensus statements for Waldeyer's ring involvement in pediatric Hodgkin lymphoma: The staging, evaluation, and response criteria harmonization (SEARCH) for childhood, adolescent, and young adult Hodgkin lymphoma (CAYAHL) group.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): Methodology statement.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Proton Therapy for Pediatric Hodgkin Lymphoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
ACR Appropriateness Criteria Pediatric Hodgkin Lymphoma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
ACR appropriateness Criteria® pediatric Hodgkin lymphoma.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 7, p. 1305, doi. 10.1002/pbc.24983
- By:
- Publication type:
- Article
Metastasectomy of Solitary Adrenal Metastasis From Small Cell Lung Cancer.
- Published in:
- Journal of Investigative Medicine High Impact Case Reports, 2017, v. 5, n. 4, p. 1, doi. 10.1177/2324709617740909
- By:
- Publication type:
- Article
Patient preferences for reducing bowel adverse events following prostate radiotherapy.
- Published in:
- PLoS ONE, 2020, v. 15, n. 7, p. 1, doi. 10.1371/journal.pone.0235616
- By:
- Publication type:
- Article
Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 7, p. 1076, doi. 10.1002/cncr.28536
- By:
- Publication type:
- Article
Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 18, p. 4619, doi. 10.1002/cncr.27398
- By:
- Publication type:
- Article